Mutations of the BRCA1 and BRCA2 genes and the possibilities for predictive testing

被引:23
作者
Gayther, SA
Ponder, BAJ
机构
[1] CRC Hum. Cancer Genet. Res. Group, Box 238, Addenbrooke's Hospital, Hills Road
来源
MOLECULAR MEDICINE TODAY | 1997年 / 3卷 / 04期
关键词
D O I
10.1016/S1357-4310(97)01017-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two cancer susceptibility genes, BRCA1 on chromosome 17q12-21 and BRCA2 on chromosome 13q12-13, are thought to be responsible for similar to 80% of families containing multiple cases of early-onset female breast cancer. Germline mutations of BRCA1 are also associated with ovarian cancer and mutations of BRCA2 are associated with an increased risk of male breast cancer, ovarian cancer, prostate cancer and pancreatic cancer. The recent isolation of both genes should make possible the identification of the genetic defect that predisposes affected individuals to breast and ovarian cancer and might lead to the use of genetic information for predictive testing.
引用
收藏
页码:168 / 174
页数:7
相关论文
共 36 条
[1]   FAMILIAL ADENOMATOUS POLYPOSIS - DESMOID TUMORS AND LACK OF OPHTHALMIC LESIONS (CHRPE) ASSOCIATED WITH APC MUTATIONS BEYOND CODON-1444 [J].
CASPARI, R ;
OLSCHWANG, S ;
FRIEDL, W ;
MANDL, M ;
BOISSON, C ;
BOKER, T ;
AUGUSTIN, A ;
KADMON, M ;
MOSLEIN, G ;
THOMAS, G ;
PROPPING, P .
HUMAN MOLECULAR GENETICS, 1995, 4 (03) :337-340
[2]   Transcriptional activation by BRCA1 [J].
Chapman, MS ;
Verma, IM .
NATURE, 1996, 382 (6593) :678-679
[3]   Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene [J].
Couch, FJ ;
Weber, BL ;
Borresen, AL ;
Brody, L ;
Casey, G ;
Devilee, P ;
Fitzgerald, M ;
Friend, S ;
Gayther, S ;
Goldgar, D ;
Murphy, P ;
Szabo, C ;
Weber, B ;
Wiseman, R ;
Anderson, T ;
Durocher, F ;
Ganguly, A ;
King, MC ;
Lenoir, G ;
Narod, S ;
Olopade, O ;
Plummer, S ;
Ponder, B ;
Serova, O ;
Simard, J ;
Stratton, M ;
Warren, B .
HUMAN MUTATION, 1996, 8 (01) :8-18
[4]   BRCA2 germline mutations in male breast cancer cases and breast cancer families [J].
Couch, FJ ;
Farid, LM ;
DeShano, ML ;
Tavtigian, SV ;
Calzone, K ;
Campeau, L ;
Peng, Y ;
Bogden, B ;
Chen, Q ;
Neuhausen, S ;
ShattuckEidens, D ;
Godwin, AK ;
Daly, M ;
Radford, DM ;
Sedlacek, S ;
Rommens, J ;
Simard, J ;
Garber, J ;
Merajver, S ;
Weber, BL .
NATURE GENETICS, 1996, 13 (01) :123-125
[5]  
EASTON DF, 1995, AM J HUM GENET, V56, P265
[6]   Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer [J].
FitzGerald, MG ;
MacDonald, DJ ;
Krainer, M ;
Hoover, I ;
ONeil, E ;
Unsal, H ;
SilvaArrieto, S ;
Finkelstein, DM ;
BeerRomero, P ;
Englert, C ;
Sgroi, DC ;
Smith, BL ;
Younger, JW ;
Garber, JE ;
Duda, RB ;
Mayzel, KA ;
Isselbacher, KJ ;
Friend, SH ;
Haber, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) :143-149
[7]  
Foster KA, 1996, CANCER RES, V56, P3622
[8]   BRCA1 MUTATIONS IN PRIMARY BREAST AND OVARIAN CARCINOMAS [J].
FUTREAL, PA ;
LIU, QY ;
SHATTUCKEIDENS, D ;
COCHRAN, C ;
HARSHMAN, K ;
TAVTIGIAN, S ;
BENNETT, LM ;
HAUGENSTRANO, A ;
SWENSEN, J ;
MIKI, Y ;
EDDINGTON, K ;
MCCLURE, M ;
FRYE, C ;
WEAVERFELDHAUS, J ;
DING, W ;
GHOLAMI, Z ;
SODERKVIST, P ;
TERRY, L ;
JHANWAR, S ;
BERCHUCK, A ;
IGLEHART, JD ;
MARKS, J ;
BALLINGER, DG ;
BARRETT, JC ;
SKOLNICK, MH ;
KAMB, A ;
WISEMAN, R .
SCIENCE, 1994, 266 (5182) :120-122
[9]   Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene [J].
Gayther, SA ;
Mangion, J ;
Russell, P ;
Seal, S ;
Barfoot, R ;
Ponder, BAJ ;
Stratton, MR ;
Easton, D .
NATURE GENETICS, 1997, 15 (01) :103-105
[10]   GERMLINE MUTATIONS OF THE BRCA1 GENE IN BREAST AND OVARIAN-CANCER FAMILIES PROVIDE EVIDENCE FOR A GENOTYPE-PHENOTYPE CORRELATION [J].
GAYTHER, SA ;
WARREN, W ;
MAZOYER, S ;
RUSSELL, PA ;
HARRINGTON, PA ;
CHIANO, M ;
SEAL, S ;
HAMOUDI, R ;
VANRENSBURG, EJ ;
DUNNING, AM ;
LOVE, R ;
EVANS, G ;
EASTON, D ;
CLAYTON, D ;
STRATTON, MR ;
PONDER, BAJ .
NATURE GENETICS, 1995, 11 (04) :428-433